Register entry
- Registered sites
- 3
- Active NDC listings
- 20
- Live patents
- 0
- Countries
- 1
- Base
- Finland
Authorisation
Registered operations
Analytical testing3Active ingredient (API) manufacture2Labelling2
Sites
Registered establishments
3| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Fermion Oy | Koivu-Mankkaan tie 6 A, Espoo, FI-02200, Finland (FIN) | Analytical testing | 3003491490401656850 |
| Fermion Oy | Orioninkatu 2, Hanko Pohjoinen, FI-10960, Finland (FIN) | Analytical testing, Active ingredient (API) manufacture, Labelling | 3002807817537993060 |
| Fermion Oy | Laaketehtaantie 2, Oulu, FI-90660, Finland (FIN) | Analytical testing, Active ingredient (API) manufacture, Labelling | 3003340711537994803 |
Catalogue
Drug listings by form and route
2020 active NDC listings: 20 bulk ingredient. By marketing category: BULK INGREDIENT 20.
| Dosage form | NDCs |
|---|---|
| powder | 20 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| fermion oy | 20 |
Catalogue
Marketed products
20| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | CROMOLYN SODIUM | powder | 12780-4960BULK INGREDIENT |
| - | Dexmedetomidine Hydrochloride | powder | 12780-4640BULK INGREDIENT |
| - | HYDROXYCHLOROQUINE SULFATE | powder | 12780-2771BULK INGREDIENT |
| - | IRINOTECAN HYDROCHLORIDE | powder | 12780-4860BULK INGREDIENT |
| - | MERCAPTOPURINE | powder | 12780-0299BULK INGREDIENT |
| - | QUETIAPINE FUMARATE | powder | 12780-4930BULK INGREDIENT |
| - | TRILACICLIB DIHYDROCHLORIDE DIHYDRATE | powder | 12780-4780BULK INGREDIENT |
| - | alprazolam | powder | 12780-4630BULK INGREDIENT |
| - | azathioprine | powder | 12780-0300BULK INGREDIENT |
| - | buspirone hydrochloride | powder | 12780-2940BULK INGREDIENT |
| - | carbidopa | powder | 12780-4420BULK INGREDIENT |
| - | diltiazem hydrochloride | powder | 12780-2960BULK INGREDIENT |
| - | flutamide | powder | 12780-4750BULK INGREDIENT |
| - | formoterol fumarate | powder | 12780-4880BULK INGREDIENT |
| - | glipizide | powder | 12780-4680BULK INGREDIENT |
| - | methotrexate | powder | 12780-0491BULK INGREDIENT |
| - | methotrexate sodium | powder | 12780-6690BULK INGREDIENT |
| - | nadolol | powder | 12780-0154BULK INGREDIENT |
| - | propafenone hydrochloride | powder | 12780-4900BULK INGREDIENT |
| - | tolnaftate | powder | 12780-4800BULK INGREDIENT |
Neighbours
Registered in the same town
2- Orion Corporation, Orion PharmaEspoo, FIN
- Pharmatory OyOulu, FIN
Compare
Comparable companies in Finland
- Orion Corporation, Orion Pharma3 sites · 3 NDC
- PCAS Finland Oy1 site · 20 NDC
- Pharmatory Oy1 site · 3 NDC
- Oy West eSales Ab Ltd1 site · 1 NDC
Enquiry
Common questions
- Is Fermion Oy FDA approved?
- Fermion Oy holds 3 FDA-registered establishments in Finland. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Fermion Oy's drugs manufactured?
- The FDA register lists Espoo; Hanko Pohjoinen; Oulu. Registered operations: analytical testing, active ingredient (API) manufacture, labelling.
- What drugs does Fermion Oy make?
- 20 products are listed under Fermion Oy in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.